Medartis (OTCMKTS:MDRSF – Get Free Report) and Inari Medical (NASDAQ:NARI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Valuation & Earnings
This table compares Medartis and Inari Medical”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Medartis | N/A | N/A | N/A | N/A | N/A |
Inari Medical | $547.47 million | 4.72 | -$1.64 million | ($0.41) | -108.39 |
Medartis has higher earnings, but lower revenue than Inari Medical.
Institutional & Insider Ownership
Profitability
This table compares Medartis and Inari Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Medartis | N/A | N/A | N/A |
Inari Medical | -10.42% | -7.51% | -5.25% |
Analyst Ratings
This is a summary of current recommendations for Medartis and Inari Medical, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Medartis | 0 | 0 | 0 | 0 | N/A |
Inari Medical | 0 | 6 | 5 | 0 | 2.45 |
Inari Medical has a consensus target price of $57.44, suggesting a potential upside of 29.26%. Given Inari Medical’s higher possible upside, analysts plainly believe Inari Medical is more favorable than Medartis.
Summary
Inari Medical beats Medartis on 5 of the 8 factors compared between the two stocks.
About Medartis
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.
About Inari Medical
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Receive News & Ratings for Medartis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medartis and related companies with MarketBeat.com's FREE daily email newsletter.